PARK CITY, Utah–(BUSINESS WIRE)–Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on July 16, 2021, the Compensation Committee of its Board of Directors granted to 17 new employees inducement stock options to purchase an aggregate of 45,200…
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Share this article
More News
Generali Stock Forecast | Rising Bond Yields, ECB Outlook
September 30, 2026
FCA Opens The Gateway To Regulated Crypto
September 30, 2026
Has CAT Stock Become A Different Bet?
September 30, 2026
Weakens below 1.3250, technical barriers sustain bearish bias
September 30, 2026
